Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas

Modern Pathology

Volumn 15, Issue 5, 2002, Pages 526-531

  Singh, Pratima K ^a   Gutmann, David H ^a   Fuller, Christine E ^a   Newsham, Irene F ^b   Perry, Arie ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Brain tumor; DAL 1; Ependymoma; Glioma; NF2; Tumor suppressor gene

Indexed keywords

CELL DNA; ERYTHROCYTE BAND 4.1 PROTEIN; MERLIN; PROTEIN DAL 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BRAIN CANCER; CANCER LOCALIZATION; CARCINOGENESIS; CHILD; CHROMOSOME 18P; CHROMOSOME 22Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; EPENDYMOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FAMILY; SPINAL CORD CANCER;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EPENDYMOMA; FEMALE; GENE DELETION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEUROFIBROMIN 2; SPINAL CORD NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 0036092448     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880558     Document Type: Article

References (30)

1. Tumors of the central nervous system
2. World Health Organization classification of tumours
3. Ependymoma: Results, prognostic factors and treatment recommendations
4. A cytogenetic study of 53 human gliomas
5. Cytogenetic abnormalities in human ependymomas
6. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma
7. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas
8. Molecular analysis of genetic changes in ependymomas
9. Involvement of chromosome 22 in ependymomas
10. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas
11. The molecular biology of ependymomas
12. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2
13. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas
14. Karyotype studies in 18 ependymomas with literature review of 107 cases
15. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas
16. Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas
17. Neurofibromatosis 1 and 2
18. Intramedullary spinal cord tumors in neurofibromatosis
19. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas
20. Molecular genetic analysis of ependymal tumors: NF2 mutations and, chromosome 22q loss occur preferentially in intramedullary spinal ependymomas
21. A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer
22. Novel regions of allelic deletion of chromosome 18p in tumors of the lung, brain, and breast
23. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas
24. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningiomas: A correlative immunohistochemical study of 175 cases
25. National Institutes of Health Consensus Development Conference
26. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
27. A role for FISH detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumor
28. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: A clinicopathologic study of 53 cases
29. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma
30. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization